Kestra Medical Technologies Ltd. (KMTS)
NASDAQ:KMTS
Total Valuation
Kestra Medical Technologies Ltd. has a market cap or net worth of $1.16B. The enterprise value is $871.09M.
Market Cap$1.16B
Enterprise Value$871.09M
Share Statistics
Kestra Medical Technologies Ltd. has 58,373,352 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding58,373,352
Owned by Insiders―
Owned by Institutions―
Financial Efficiency
Kestra Medical Technologies Ltd.’s return on equity (ROE) is 0.45 and return on invested capital (ROIC) is -655.44%.
Return on Equity (ROE)0.45
Return on Assets (ROA)-2.05
Return on Invested Capital (ROIC)-655.44%
Return on Capital Employed (ROCE)-6.55
Revenue Per Employee199.38K
Profits Per Employee-379.38K
Employee Count300
Asset Turnover0.61
Inventory Turnover8.34
Valuation Ratios
The current PE Ratio of Kestra Medical Technologies Ltd. is ―. Kestra Medical Technologies Ltd.’s PEG ratio is -0.69.
PE Ratio―
PS Ratio38.89
PB Ratio-5.17
Price to Fair Value-5.17
Price to FCF-12.76
Price to Operating Cash Flow-12.09
PEG Ratio-0.69
Income Statement
In the last 12 months, Kestra Medical Technologies Ltd. had revenue of 59.81M and earned -113.81M in profits. Earnings per share was -5.13.
Revenue59.81M
Gross Profit24.21M
Operating Income-106.38M
Pretax Income-113.68M
Net Income-113.81M
EBITDA-97.98M
Earnings Per Share (EPS)-5.13
Cash Flow
In the last 12 months, operating cash flow was -86.68M and capital expenditures -33.27M, giving a free cash flow of -119.95M billion.
Operating Cash Flow-86.68M
Free Cash Flow-119.95M
Free Cash Flow per Share-2.05
Dividends & Yields
Kestra Medical Technologies Ltd. pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share―
Dividend Yield―
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta1.15
52-Week Price Change-12.91%
50-Day Moving Average25.68
200-Day Moving Average―
Relative Strength Index (RSI)58.22
Average Volume (3m)310.69K
Important Dates
Kestra Medical Technologies Ltd. upcoming earnings date is Apr 20, 2026, After Close (Confirmed).
Last Earnings DateDec 11, 2025
Next Earnings DateApr 20, 2026
Ex-Dividend Date―
Financial Position
Kestra Medical Technologies Ltd. as a current ratio of 0.45, with Debt / Equity ratio of 1.49%
Current Ratio0.45
Quick Ratio0.35
Debt to Market Cap0.04
Net Debt to EBITDA-0.48
Interest Coverage Ratio-13.65
Taxes
In the past 12 months, Kestra Medical Technologies Ltd. has paid 135.00K in taxes.
Income Tax135.00K
Effective Tax Rate>-0.01
Enterprise Valuation
Kestra Medical Technologies Ltd. EV to EBITDA ratio is -14.66, with an EV/FCF ratio of -13.20.
EV to Sales40.22
EV to EBITDA-14.66
EV to Free Cash Flow-13.20
EV to Operating Cash Flow-15.49
Balance Sheet
Kestra Medical Technologies Ltd. has $291.32M in cash and marketable securities with $4.29M in debt, giving a net cash position of $287.04M billion.
Cash & Marketable Securities$291.32M
Total Debt$4.29M
Net Cash$287.04M
Net Cash Per Share$4.92
Tangible Book Value Per Share-$4.23
Margins
Gross margin is 48.75%, with operating margin of -305.83%, and net profit margin of -338.39%.
Gross Margin48.75%
Operating Margin-305.83%
Pretax Margin-338.30%
Net Profit Margin-338.39%
EBITDA Margin-274.34%
EBIT Margin-315.91%
Analyst Forecast
The average price target for Kestra Medical Technologies Ltd. is $28.80, which is 11.43% higher than the current price. The consensus rating is Strong Buy
Price Target$28.80
Price Target Upside51.42% Upside
Analyst ConsensusStrong Buy
Analyst Count6
Revenue Growth Forecast62.06%
EPS Growth Forecast-41.97%